Compare Medpace Holdings Inc (MEDP) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Paychex, Inc. — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Paychex, Inc. trades at $103.98 (market cap $37.19B). The key difference: Paychex, Inc. is far larger — about 2.2× Medpace Holdings Inc's market cap, and Paychex, Inc. pays a 4.56% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Paychex, Inc. for 56 Days on average.
| MEDP | PAYX | |
|---|---|---|
Market Cap | $16.82B | $37.19B |
Volume | 223,093 | 3,344,316 |
Sector | Health | Industrials |
52-Week High | $630.19 | $128.59 |
52-Week Low | $393.42 | $85.57 |
Typical Hold Time | 14 Days | 56 Days |
Enterprise Value | $16.44B | $40.87B |
Dividend Yield | — | 4.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down slightly by 0.26% on the day, with a neutral technical outlook and bullish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected on October 21, 2026. Revenue and net income are projected to grow in 2026, supported by a robust 17.67% net income margin and exceptional ROE of 162.15%. However, valuation ratios like P/E of 35.41 and P/B of 38.77 suggest a premium pricing relative to peers.
The stock offers upside to the consensus price target of $620.44, but risks include high valuation multiples, CEO stock sales, and mixed institutional positioning. Investors should weigh strong profitability against potential overvaluation and monitor Q3 earnings for continued momentum.
Paychex (PAYX) trades at $104.46, up 2.87% on the day, showing resilience after recent volatility. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages, while fundamentals remain solid with consistent earnings beats, a 27.35% net income margin, and a forward P/E of 20.73. Recent news highlights strong Q1 2027 results but also concerns over dividend sustainability and labor market exposure.
The outlook is cautiously optimistic, supported by robust profitability and a consensus price target of $111, offering potential upside. Key risks include sensitivity to small business employment trends, high valuation multiples, and investor scrutiny of cash flow allocation. The stock presents a hold case for income-focused investors, balancing dividend yield against growth deceleration concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
